Christine Leemann

Zurich, ZH 8057, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Correction: Schlösser et al. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells. Non-Coding RNA 2025, 11, 8.

Correction: Schlösser et al. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells. Non-Coding RNA 2025, 11, 8.

Journal: Non-coding RNA
Published: May 08, 2025

Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells.

Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells.

Journal: Non-coding RNA
Published: November 10, 2024

Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database.

Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database.

Journal: PLOS digital health
Published: August 21, 2024

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.

Journal: The Journal of infectious diseases
Published: May 05, 2023

Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.

Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.

Journal: The Journal of antimicrobial chemotherapy
Published: April 26, 2023

The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease.

The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease.

Journal: The Journal of infectious diseases
Published: January 05, 2022

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.

Journal: The Journal of infectious diseases
Published: December 10, 2021

A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells.

A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells.

Journal: Viruses
Published: February 03, 2021

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection.

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection.

Journal: JCI insight
Published: September 03, 2020

Long-term experimental evolution of HIV-1 reveals effects of environment and mutational history.

Long-term experimental evolution of HIV-1 reveals effects of environment and mutational history.

Journal: PLoS biology
Published: April 27, 2020

Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.

Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.

Journal: The Journal of antimicrobial chemotherapy
Published: April 23, 2020

Parallel Evolution of HIV-1 in a Long-Term Experiment.

Parallel Evolution of HIV-1 in a Long-Term Experiment.

Journal: Molecular biology and evolution
Published: June 29, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026